ESC Professional Premium Access

Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study

Congress Presentation

About the speaker

Associate Professor Christina Christersson

Uppsala University, Uppsala (Sweden)
4 presentations
1 follower

4 more presentations in this session

To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis

Speaker: Doctor A. Kaur (New York City, US)


Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis

Speaker: Doctor A. Kaur (New York City, US)


Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

Speaker: Doctor M. Bak (Seoul, KR)


Hypoattenuated leaflet thickening is associated with silent brain injury

Speaker: Doctor A. Nagy (Budapest, HU)


Access the full session

Thrombosis and anticoagulation in valvular heart disease

Speakers: Associate Professor C. Christersson, Doctor A. Kaur, Doctor A. Kaur, Doctor M. Bak, Doctor A. Nagy

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb